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Abstract
The current study aims to determine the genotoxic and antigenotoxic potential of four newly synthesized
dihydropyridine derivatives using Escherichia coli WP2 and Ames/Salmonella bacterial reversion assay systems.
The bacterial mutant tester strains, E. coli WP2uvrA with a point mutation and Salmonella typhimurium TA1537
with a frameshift mutation, were used to determine genotoxic potentials of the test compounds. To determine
antigenotoxic potentials of the test compounds, the same strains were also used together with positive
mutagens N-methyl-N0-nitro-N-nitrosoguanidine (MNNG) for E. coli WP2uvrA and 9-aminoacridine (9-AA) for
S. typhimurium TA1537. According to the results, neither of the test compounds showed significant genotoxic
activity on both tester strains at the tested concentrations. However, except compound 4, all the test
compounds showed significant antigenotoxic activity on MNNG- or/and 9-AA-induced mutations. The inhibi-
tion rates of mutagenesis ranged from 27.0% (compound 2: 2.5 mM/plate) to 65.0% (compound 2: 0.5 mM/
plate) for MNNG and from 30.6% (compound 2: 2 mM/plate) to 58.5% (compound 1: 1 mM/plate) for 9-AA
genotoxicity. According to these results, it is concluded that all the test compounds do not have a mutagenic
potential on the bacterial strains at the tested concentrations, and some of them have antigenotoxic potentials
against MNNG- and 9-AA-induced mutagenesis.
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Introduction
Dihydropyridines (DHPs) are of importance in bio-
logical systems as a class of useful drugs, particu-
larly as antioxidants. Some of the representative
compounds of this class possess acaricidal, insectici-
dal, bactericidal, herbicidal, and several inhibitor
activities (Abadi et al., 2009, 2010; Bertrand et al.,
2010; Choi et al., 2010; Khadilkar and Borkar,
1998; Li et al., 2007; Marsh et al., 1988; Tu et al.,
2004). DHP drugs, namely nifedipine, nicardipine,
and amlodipine, are cardiovascular agents for the
treatment of hypertension (Augstein et al., 1972;
Buhler and Kiowski, 1987; Harb, 2004; Zolfigol
et al., 2006). Recent studies have revealed that 1,4-
DHPs exhibit several medicinal applications that
include neuroprotectant and platelet antiaggregatory
activity, in addition to cerebral anti-ischemic activity
in the treatment of Alzheimer’s disease and as
chemosensitizer in tumor therapy (Boer and Gekeler,
1995; Bretzel et al., 1993; Kumar et al., 2011).
Due to their wide-range usage potential that is
directly associated with human health-care, determi-
nation of genotoxic and antigenotoxic properties of
1,4-DHP derivatives is a very important strategy.
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Escherichia coli WP2 and Ames/Salmonella
bacterial reversion assay systems are two important
in vitro test systems commonly used for determining
the genotoxic and antigenotoxic properties of natural
or synthetic materials obtained from various sources
(Mortelmans and Riccio, 2000; Mortelmans and
Zeiger, 2000).
Thus, the present study was designed to evaluate
the genotoxic and antigenotoxic potential of four
newly synthesized 1,4-DHP derivatives (Figure 1)
using E. coli WP2 and Ames/Salmonella bacterial
reversion assay systems.
Material and methods
Synthesis of DHP derivatives
To a stirred mixture of 1,3-dione compound (1 mM),
ethyl acetoacetate (1 mM) and Yb(OTf)3 (5 mol%) in
ethanol (5 mL), aldehyde (1 mM), and ammonium
acetate (1 mM) were added at room temperature. The
reaction mixture was stirred for 6 h thin layer chroma-
tography (TLC) at room temperature, and then the
resulting solid product was filtered, washed with water,
and dried in a vacuum to afford the crude product.
A pure product was obtained by further recrystalliza-
tion using ethanol as a solvent. The filtrate containing
the catalyst could be evaporated under reduced pres-
sure to give a white solid. After completion of the reac-
tion (monitored by TLC), the reaction mass was filtered
in hot condition to separate the catalyst and poured on
ice-water. The obtained solid condensation product
was further purified by recrystallization in ethanol. The
recovered catalyst was washed with ethyl acetate, then
dried at 70C and activated at 120C prior to use for
next run in model reaction. It was found that the recov-
ered catalyst shows a good yield with three successive
reactions (Wang et al., 2005).
Chemicals
Direct acting mutagens, N-methyl-N0-nitro-N-nitroso-
guanidine (MNNG) and 9-aminoacridine (9-AA), were
obtained from ABCR GmbH & Co. KG (Karlsruhe,
Germany) and Merck (Hohenbrunn, Germany), respec-
tively. Other solvents and pure chemicals including
magnesium sulfate (MgSO4), sodium ammonium
phosphate (Na2NH2PO4), D-glucose, D-biotin, sodium
chloride (NaCl), L-histidine HCl, L-tryptophane,
sodium phosphate-dibasic (Na2HPO4), crystal violet,
citric acid monohydrate, potassium phosphate-dibasic
(K2HPO4), and sodium phosphate-monobasic
(NaH2PO4) were obtained from Difo (New Jersey,
USA), Fluka (Steinheim, Germany), Merck (Darm-
stadt, Germany), and Sigma (St Louis, USA).
Bacterial strains
Salmonella typhimurium TA1537 (ATCC1 Number:
29630) strain was provided by The American Type
Culture Collection – Bacteria Department of George-
town University, Washington, USA, and E. coli
WP2uvrA (ATCC1 Number: 49979) strain was
provided by LGC standards Middlesex, UK. All
strains were stored at 80C. Working cultures were
prepared by inoculating nutrient broth with the frozen
cultures, followed by an overnight incubation at 37C
with gentle agitation (Gulluce et al., 2010).
Viability assays and determination of test
concentrations
The toxicity of chemicals toward E. coli WP2uvrA
and S. typhimurium TA1537 was determined as
described in detail elsewhere (Santana-Rios et al.,
2001; Yu et al., 2001). These tests confirmed that
there was normal growth of the background lawn,
spontaneous colony numbers within the regular range,
and no significant reduction in cell survival. Thus, for
the concentrations and conditions reported here, no
toxicity or other adverse effects were observed.
Bacterial reversion assay
The bacterial genotoxicity and antigenotoxicity assays
were performed according to the studies described in
detail elsewhere (Mortelmans and Riccio, 2000;
Mortelmans and Zeiger, 2000). The known mutagens
9-AA (in methanol: 40 mg/plate) for S. typhimurium
TA1537 and MNNG (in 10% dimethylsulfoxide
(DMSO): 1 mg/plate) for E. coli WP2uvrA were used
as positive controls, and 10% DMSO was used as
negative control in these studies (Gulluce et al., 2011).
In the genotoxicity test performed with TA1537
strain of S. typhimurium, 100 mL of the overnight
bacterial culture, 50 mL of the test compounds at
different concentrations (0.5, 1, 1.5, 2 and 2.5 mM/
plate in 10% DMSO), and 500 mL of buffer solution
were added to 2 mL of the top agar containing
0.5 mM histidine/biotin. The mixture was poured onto
minimal glucose agar plates. Histidine-independent
revertant colonies and viable cells were scored on
plates after incubation at 37C for 48 h.
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In the antigenotoxicity test performed with the
same strain, 100 mL of the overnight bacterial cul-
ture, 50 mL of mutagen solution, 50 mL of the test
compounds at different concentrations (0.5, 1, 1.5,
2 and 2.5 mM/plate in 10% DMSO), and 500 mL
of buffer were added to 2 mL of the top agar con-
taining 0.5 mM histidine/biotin. The mixture was
poured onto minimal glucose agar plates. Histidine-
independent revertant colonies and viable cells were
scored on plates after incubation at 37C for 48 h.
The procedures of genotoxicity and antigenotoxi-
city assays described for the Ames/Salmonella assay
are all applicable to the E. coli WP2 reverse mutation
assay. The only procedural difference is the addition
of limited tryptophan (0.01 mM) instead of histidine
to the top agar (Mortelmans and Riccio, 2000).
The plate incorporation method was used to assess
the results of genotoxicity and antigenotoxicity assays
(Maron and Ames, 1983).
In genotoxicity assays, the mutagenic index was
calculated for each concentration, which is the
average number of revertants per plate divided by
the average number of revertants per plate with the
negative (solvent) control. A sample is considered
genotoxic when a dose–response relationship was
observed and a twofold increase in the number of
mutants with at least one concentration was observed
(Gulluce et al., 2010).
In genotoxicity assays, the inhibition of mutageni-
city was calculated using the following equation
(M: number of revertants/plate induced by mutagen
alone, S0: number of spontaneous revertants, S1: num-
ber of revertants/plate induced by the test compound
plus the mutagen)
%Inhibition ¼ 1 M S1ð Þ= M S0ð Þ½   100
A 25–40% inhibition was defined as moderate
antigenotoxicity, 40% or more inhibition as strong
Table 1. The mutagenicity assay results of test compounds for Escherichia coli WP2uvrA and Salmonella typhimurium









Mean + SE Mutation (%) Mean + SE Mutation (%)
Compound 1 2.5 29.33 + 0.95 – 23.33 + 1.11 –
2.0 30.16 + 0.87 – 23.16 + 1.24 –
1.5 30.50 + 1.38 – 21.83 + 0.79 –
1.0 32.00 + 1.06 – 26.50 + 1.33 –
0.5 30.50 + 0.84 – 25.16 + 0.74 –
Compound 2 2.5 32.66 + 0.80 – 25.33 + 1.17 –
2.0 30.00 + 1.12 – 24.66 + 1.42 –
1.5 32.33 + 1.22 – 24.83 + 1.37 –
1.0 31.66 + 1.20 – 24.50 + 0.92 –
0.5 31.33 + 1.28 – 24.83 + 1.40 –
Compound 3 2.5 28.16 + 0.83 – 22.83 + 1.01 –
2.0 33.00 + 1.06 – 25.50 + 1.17 –
1.5 31.00 + 1.23 – 23.66 + 1.08 –
1.0 31.50 + 1.54 – 24.50 + 0.84 –
0.5 31.66 + 0.98 – 25.16 + 1.30 –
Compound 4 2.5 30.33 + 1.02 – 25.33 + 0.71 –
2.0 33.16 + 0.87 – 26.16 + 0.79 –
1.5 30.33 + 0.98 – 25.66 + 1.52 –
1.0 31.16 + 1.47 – 24.83 + 1.19 –
0.5 31.66 + 1.56 – 27.33 + 0.88 –
MNNGa 499.83 + 8.26
9-AAa 448.66 + 10.95
DMSOa (ml/plate) 30.66 + 1.20 26.33 + 0.61
MNNG: N-methyl-N0-nitro-N-nitrosoguanidine; DMSO: dimethylsulfoxide; 9-AA: 9-aminoacridine.
aMNNG (1 mg/plate) and 9-AA (40 mg/plate) were used as positive controls for E. coli WP2uvrA and S. typhimurium TA1537 strains,
respectively. DMSO (100 ml/plate) was used as negative control.
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antigenotoxicity, and 25% or less inhibition as no anti-
genotoxicity (Gulluce et al., 2011; Turhan et al., 2012).
Statistical analysis
The results are presented as the average and standard
error of three experiments with triplicate plates/dose
experiment. The data were further analyzed for
statistical significance using analysis of variance,
and the difference among means was compared by
high-range statistical domain using Tukey’s test. A
level of probability was taken as p < 0.05 indicating
statistical significance (Gulluce et al., 2011; Turhan
et al., 2012).
Results
The genotoxicity assay results showed that any test
compound has no mutagenic activity on E. coli
WP2uvrA and S. typhimurium TA1537 bacterial tester
strains at applied concentrations (Table 1 and
Figure 2(a) and (b)).
The antigenotoxic potentials of test materials were
also examined against MNNG and 9-AA in E. coli
WP2uvrA and S. typhimurium TA1537, respectively.
The results were evaluated using standard plate incor-
poration method and summarized in Table 2 showing
the antigenotoxic activities of the test materials,
which were tested at five different concentrations
(0.5, 1, 1.5, 2 and 2.5 mM/plate).
According to the antigenotoxicity assay results
performed with MNNG and E. coli WP2uvrA strain
carrying a base substation point mutation,
compounds 2 and 3 have significant antimutagenic
activity at various test concentrations between 0.5 and
2.5 mM/plate. The inhibition rates of these substances
ranged from 27.0% (compound 2: 2.5 mM/plate)
to 65.0% (compound 2: 0.5 mM/plate; Table 2 and
Figure 3(a)).
Figure 2. The genotoxicity results of the test compounds on E. coli WP2uvrA (a) and S. typhimurium TA1537 (b) mutant
bacterial strains.
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According to the other antimutagenicity assay
results performed with 9-AA and S. typhimurium
TA1537 strain carrying a frameshift mutation,
compounds 1 and 2 have significant antimutagenic
activity against 9-AA mutagenicity on S. typhimurium
TA1537 strain at the tested concentrations. The
inhibition rates were between 30.6% (compound 2:
2 mM/plate) and 58.5% (compound 1: 1.5 mM/plate;
Table 2 and Figure 3(b)).
Discussion
Synthetic derivatives of 1,4-DHP possess important
biochemical and pharmacological properties. They
show modulating activity on cardiovascular and
neuronal processes, on corticosteroid regulatory cir-
cuits, prevent inflammatory and diabetic processes,
and some show antineoplastic, geroprotective,
radioprotective, and radiosensitizing effects (Briede
et al., 1999, 2002; Emanuél et al., 1985; Ivanov
et al., 1990, 2004; Klegeris et al., 2002;
Liutkevicius et al., 1999; Misane et al., 1998;
Vartanian et al., 2004). Some of the positive effects
of 1,4-DHPs are long-term; and due to their low or
very low toxicity, this group of compounds appears
to offer promise for medical applications (Goncharova
et al., 1995; Klusa et al., 1996). Among 12 screened
1,4-DHPs that differed in chemical structure, six
b-carbonyl-1,4-DHPs that are analogues of dihydroni-
cotinamide, the hydrogen- and electron-transferring
moiety of the redox coenzymes NADH and NADPH,
showed antimutagenic activity and significantly
reduced spontaneous and alkylation-induced point
mutations and chromosome breaks in germ cells of
Drosophila, alkylation-induced micronuclei in
mouse bone-marrow cells, and radiation-induced
Table 2. The antimutagenicity assay results of test compounds for Escherichia coli WP2uvrA and Salmonella typhimurium
TA1537 bacterial tester strains.






Mean + SE Inhibition (%) Mean + SE Inhibition (%)
Compound 1 2.5 349.33 + 8.37 – 356.00 + 6.74 24.3
2.0 353.50 + 8.42 – 319.00 + 7.30 32.1a
1.5 361.33 + 9.26 – 355.00 + 6.49 24.5
1.0 360.66 + 9.60 – 195.00 + 7.20 58.5a
0.5 352.83 + 7.57 – 424.33 + 6.90 9.7
Compound 2 2.5 252.50 + 7.89 27.0a 280.00 + 7.82 40.4a
2.0 171.00 + 8.60 50.6a 326.00 + 7.52 30.6a
1.5 213.00 + 6.89 38.4a 200.00 + 6.32 57.4a
1.0 160.50 + 8.45 53.6a 325.00 + 7.68 30.9a
0.5 121.00 + 8.74 65.0a 313.00 + 6.31 33.4a
Compound 3 2.5 251.50 + 7.88 27.3a 459.16 + 7.08 2.3
2.0 160.00 + 7.89 53.8a 479.50 + 7.34 –
1.5 213.00 + 8.81 38.4a 480.66 + 7.88 –
1.0 168.50 + 8.17 51.3a 478.66 + 6.74 –
0.5 149.00 + 7.57 56.9a 485.66 + 6.60 –
Compound 4 2.5 348.16 + 7.92 – 479.66 + 7.05 –
2.0 349.16 + 9.24 – 487.66 + 6.58 –
1.5 349.50 + 7.15 – 479.66 + 7.69 –
1.0 361.16 + 7.36 – 485.16 + 7.12 –
0.5 360.33 + 7.94 – 491.16 + 5.99 –
MNNGb 346.00 + 8.53
9-AAb 470.00 + 8.62
DMSOb (ml/plate) 29.83 + 1.37 25.16 + 1.04
MNNG: N-methyl-N0-nitro-N-nitrosoguanidine; DMSO: dimethylsulfoxide; 9-AA: 9-aminoacridine.
ap < 0.05.
bMNNG (1 mg/plate) and 9-AA (40 mg/plate) were used as positive controls for E. coli WP2uvrA and S. typhimurium TA1537 strains,
respectively. DMSO (100 ml/plate) was used as negative control.
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chromosome aberrations and other cytogenetic end-
points in fish (Goncharova, 2000; Goncharova
et al., 2001; Goncharova and Kuzhir, 1989).
In the current study, the genotoxic and antigeno-
toxic properties of newly synthesized four DHP
derivatives have been investigated using E. coli
WP2 and Ames/Salmonella bacterial test systems.
According to the results, none of the test compounds
showed mutagenic activity on E. coli WP2uvrA and S.
typhimurium TA1537 tester strains. However, some of
them have significant antimutagenic activity against
MNNG- and 9-AA-induced mutagenesis on the same
strains at the tested concentrations.
The mutagens used to determine the antimutagenic
activity of the test substances in this study were
MNNG for WP2uvrA and 9-AA for TA1537.
MNNG is a well-known carcinogen, and it is
known to exert its mutagenic and lethal effects by
methylation of DNA (Kumaresan et al., 1995).
Previous studies showed that the formation of
O6-methylguanine, which is one of its important
products, appears to be responsible for its mutagenic
action (Eadie et al., 1984; Loveless, 1969). The results
of this study showed that both the test compounds
have antimutagenic activity against MNNG at tested
concentrations. The antimutagenicity of these sub-
stances may be explained with their inhibitor activity
on the production of O6-methylguanine.
9-AA was used in this study as a simple intercalator
mutagen. Through intercalation, 9-AA induces frame-
shift mutations at hotspots in which a single base,
especially guanine, is repeated (Hoffman et al.,
2003). The antimutagenicity assay performed with
S. typhimurium TA1537 and 9-AA depends on the
inhibition of this mechanism by test substances,
which were thought as antimutagenic. In this study,
Figure 3. The antigenotoxicity results of the test compounds on MNNG- and 9-AA-induced mutations in Escherichia coli
WP2uvrA (a) and Salmonella typhimurium TA1537 (b) mutant bacterial strains, respectively. MNNG: N-methyl-N0-nitro-N-
nitrosoguanidine; 9-AA: 9-aminoacridine.
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the results suggested that compounds 1 and 2 have
antimutagenic activity in TA1537 strain at different
concentrations (Table 2). This antimutagenic effect
may be due to their inhibition capabilities by blocking
9-AA binding to DNA.
In conclusion, four newly synthesized 1,4-DHP
derivatives, which were investigated in the present
study, can be thought as genotoxically safe at the
tested concentrations because they do not show muta-
genic activity. Besides, some of them showed signif-
icant antimutagenic properties that can be valuable for
the prevention and drug discovery studies against
MNNG and 9-AA genotoxicity.
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